2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 374.22

-0.2%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: THE ANT who wrote (152700)	1/25/2020 5:31:51 PM
From: Lazarus	Read Replies (1) of 217920

BETTER YET -- EXPLAIN THIS PLEASE! NOTE THE DATE OF EXPIRATION --- TODAY! ______________________________ *Coronavirus isolated from humans* Abstract Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use. US7220852B1United States Download PDF Find Prior Art Similar Inventor Paul A. Rota Larry J. Anderson William J. Bellini Cara Carthel Burns Raymond Campagnoli Qi Chen James A. Comer Shannon L. Emery Dean D. Erdman Cynthia S. Goldsmith Charles D. Humphrey Joseph P. Icenogle Thomas G. Ksiazek Stephan S. Monroe William Allan Nix M. Steven Oberste Teresa C. T. Peret Pierre E. Rollin Mark A. Pallansch Anthony Sanchez Suxiang Tong Sherif R. ZakiCurrent Assignee Centers of Disease Control and Prevention (Department of Health and Human Services) Worldwide applications 2004 US 2007 US Application US10/822,904 events 2003-04-25 Priority to US46592703P 2004-04-12 Application filed by Centers of Disease Control and Prevention (Department of Health and Human Services) 2004-04-12 Priority to US10/822,904 2007-05-22 Application granted 2007-05-22 Publication of US7220852B1 2007-06-28 Assigned to THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION 2020-01-25 Application status is Expired - Fee Related 2024-04-12 Anticipated expiration Info Patent citations (3) Non-patent citation _______________________________ SOURCE SCREEN SHOT OF PAGE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next